TORONTO and GLIL YAM, Israel — IM Cannabis Corp., an international medical cannabis company, has applied for a voluntary delisting of its common shares from the Canadian Securities Exchange (CSE). The delisting from the CSE will not affect the Company’s listing on NASDAQ and its shares will continue trading on the NASDAQ.
The company is entertaining potential transactions that, if completed while the company is listed on the CSE, would require the company to incur unnecessary burdensome costs, approvals and delay. The company believes that the trading volume of its shares on the CSE no longer justifies the expenses, administrative efforts, and regulatory burdens required to maintain a dual listing. The company also believes that delisting from the CSE will create a central marketplace for its shares on the Nasdaq and ultimately benefit the long-term liquidity and shareholder value of the…
